Medication for treating lung injury
AssigneeShanghai Seme Cell Technology Co., Ltd
InventorsXifan HOU, Wenjie ZHANG, Bin WANG
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a medication for treating a lung injury. Specifically, the present disclosure provides a use of an annexin in preparation of a composition or a formulation. The composition or formulation has one or more uses selected from the following group consisting of: (i) preventing and/or treating a lung injury; and (ii) reducing neutrophil aggregation.
Claims40
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method for (i) preventing and/or treating a lung injury and/or (ii) reducing a quantity of neutrophils, comprising:
- administering annexin at a dose of 0.2-5 mg/kg to a subject, wherein the subject is a human or a non-human mammal.
Dependencies are inferred from the claim text.